Maiden Pharmaceuticals had license to export, not locally sell cough & cold syrup, India says

India's health and welfare ministry said Thursday that Maiden Pharmaceuticals had the license to only export four drugs that are now linked to have killed 66 children in Gambia. ​​​​"Four drugs, out of 23, named Promethazine Oral Solution BP, Kofexnalin Baby Cough Syrup, MaKoff Baby Cough Syrup and MaGrip n Cold Syrup, are not sold in India," stated a press release.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news